From: Indirect-comparison meta-analysis of treatment options for patients with refractory Kawasaki disease
 | Infliximab group (%) |  | IVMP group (%) | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Variable | Burns | Youn | Tremoulet | Son | Masaaki | Miura05 | Miura08 | Teraguchi | Sundel | Newburger |
Transient hepatomegaly | 41.7 | – | – | 19 |  | – | – | – | – | – |
Chills | – | 0 | – | – |  | – | – | – | 6 | – |
Rash | – | 10 | 1 | – | 12.5 | – | – | – | – | – |
Headache | – | – | 2 | – |  | – | – | – | – | 5 |
Hemolytic anemia | – | – | 2 | – |  | – | – | – | – | 1 |
Seizure | – | – | 0 | – |  | – | – | – | – | – |
Hepatitis | – | – | 0 | – |  | – | – | – | – | – |
Hypertension | – | – | 0 | – |  | 90 | 86 | – | 6 | – |
Coagulopathy | – | – | 0 | – |  | 27 | – | – | – | – |
Bradycardia | – | – | – | – |  | 82 | 86 | – | – | – |
Hypothermia | – | – | – | – |  | 1 | 14 | – | – | – |
Hypotension | – | – | – | – |  | – | – | – | – | 5 |
Hyperglycemia | – | – | – | – |  | 55 | 71 | – | – | – |
Embolism | – | – | – | – |  | 0 | 0 | – | – | – |
Stool blood | – | – | – | – |  | 0 | 0 | 7 | – | – |
Vomiting | – | – | – | – | 6.3 | – | – | – | 0 | – |
Heart failure | – | – | – | – |  | – | – | – | 0 | 0 |
Shock | – | – | – | – |  | – | – | – | – | 1 |